Screenshot 2021-10-14 at 9.02.35 AM
Tuesday, August 25, 2026
20.9
C
Bengaluru
Hot topics
Will Paras IPO Disrupt Non-Metro Hospitals Like Mankind Pharma?
India's next healthcare opportunity may not be in the...
What pharma marketers get wrong about digital
Marketers often think that everything is new in the digital world. They have simply forgotten the first principle, which is to serve the customers – to have a customer-centric view and not a product-centric one.
Indian Pharma Market (IPM) Highlights – January 2025
Overall IPM Performance:
Monthly Growth: IPM monthly growth reached 8.4% in...
How To See Dr Reddy’s Nestle In The Wellness Shift
GLP-1 medicines such as semaglutide and tirzepatide are changing...
How To Power The India Biopharma Regulatory Revolution Now
Beyond the Pharmacy of the World: Why India's Biopharma...
Will Mounjaro Disrupt Existing Therapy Areas Like Cardiology?
Something remarkable has happened in the Indian pharmaceutical market....
Can India Pivot From Low-Cost Medical Tourism to Trusted Medical Value Travel?
C-Suite Executive Summary
India stands at a pivotal juncture in...
Rajesh Bhogavalli has been appointed as Chief Commercial Officer of ACG Group.
With over 25 years of leadership experience across commercial...
How To See Dr Reddy’s Nestle In The Wellness Shift
GLP-1 medicines such as semaglutide and tirzepatide are changing...
How To Power The India Biopharma Regulatory Revolution Now
Beyond the Pharmacy of the World: Why India's Biopharma...
Will Mounjaro Disrupt Existing Therapy Areas Like Cardiology?
Something remarkable has happened in the Indian pharmaceutical market....
Can India Pivot From Low-Cost Medical Tourism to Trusted Medical Value Travel?
C-Suite Executive Summary
India stands at a pivotal juncture in...
Rajesh Bhogavalli has been appointed as Chief Commercial Officer of ACG Group.
With over 25 years of leadership experience across commercial...
How To See Dr Reddy’s Nestle In The Wellness Shift
GLP-1 medicines such as semaglutide and tirzepatide are changing...
How To Power The India Biopharma Regulatory Revolution Now
Beyond the Pharmacy of the World: Why India's Biopharma...
Will Mounjaro Disrupt Existing Therapy Areas Like Cardiology?
Something remarkable has happened in the Indian pharmaceutical market....
Can India Pivot From Low-Cost Medical Tourism to Trusted Medical Value Travel?
C-Suite Executive Summary
India stands at a pivotal juncture in...
Rajesh Bhogavalli has been appointed as Chief Commercial Officer of ACG Group.
With over 25 years of leadership experience across commercial...
How To See Dr Reddy’s Nestle In The Wellness Shift
GLP-1 medicines such as semaglutide and tirzepatide are changing...
How To Power The India Biopharma Regulatory Revolution Now
Beyond the Pharmacy of the World: Why India's Biopharma...
Will Mounjaro Disrupt Existing Therapy Areas Like Cardiology?
Something remarkable has happened in the Indian pharmaceutical market....
Can India Pivot From Low-Cost Medical Tourism to Trusted Medical Value Travel?
C-Suite Executive Summary
India stands at a pivotal juncture in...
Rajesh Bhogavalli has been appointed as Chief Commercial Officer of ACG Group.
With over 25 years of leadership experience across commercial...
Hot topics
Boehringer Ingelheim India focuses on partnerships in NCD management
Addressing the media at a roundtable this morning, Vani Manja, Managing Director, Boehringer Ingelheim India said, “Boehringer Ingelheim India aspires to be amongst the top five multinational pharmaceutical companies in India over the next few years. We have been enabling access to our innovator products to patients across India and the neighbouring markets in the diabetes, cardiovascular, stroke and respiratory diseases segments. Our plan in these therapy areas is to build sustainable partnerships to ensure an ecosystem of access and care for patients. We have initiated action in that direction.”
The Antifungal Blind Spot: India’s Quiet Clinical Crisis
A market analysis and clinical commentary on the growing...
Indian Pharmaceutical Innovation – Post TRIPS
It is the twentieth anniversary of the new patent act in January 2025. The post-patent (P20) era is a story of resilience, determination, and charting a course that set global ambitions, a story of finding opportunity in adversity. It is a story for case studies in business schools, in international studies, in global health efforts.
Inspirational Frontline Leadership
The last issue of 2016, with articles from K. Hariram and Vivek Hattangadi and new authors, Dr. Ashwin Bonde and Diksha Fouzdar. Diksha's article is the highlight of this issue - an in-depth look at how to embed compliance in the very DNA of a pharma company.
How To See Dr Reddy’s Nestle In The Wellness Shift
GLP-1 medicines such as semaglutide and tirzepatide are changing...
How To Power The India Biopharma Regulatory Revolution Now
Beyond the Pharmacy of the World: Why India's Biopharma...
Will Mounjaro Disrupt Existing Therapy Areas Like Cardiology?
Something remarkable has happened in the Indian pharmaceutical market....
Can India Pivot From Low-Cost Medical Tourism to Trusted Medical Value Travel?
C-Suite Executive Summary
India stands at a pivotal juncture in...
Rajesh Bhogavalli has been appointed as Chief Commercial Officer of ACG Group.
With over 25 years of leadership experience across commercial...
How To See Dr Reddy’s Nestle In The Wellness Shift
GLP-1 medicines such as semaglutide and tirzepatide are changing...
How To Power The India Biopharma Regulatory Revolution Now
Beyond the Pharmacy of the World: Why India's Biopharma...
Will Mounjaro Disrupt Existing Therapy Areas Like Cardiology?
Something remarkable has happened in the Indian pharmaceutical market....
Can India Pivot From Low-Cost Medical Tourism to Trusted Medical Value Travel?
C-Suite Executive Summary
India stands at a pivotal juncture in...
Rajesh Bhogavalli has been appointed as Chief Commercial Officer of ACG Group.
With over 25 years of leadership experience across commercial...
How To See Dr Reddy’s Nestle In The Wellness Shift
GLP-1 medicines such as semaglutide and tirzepatide are changing...
How To Power The India Biopharma Regulatory Revolution Now
Beyond the Pharmacy of the World: Why India's Biopharma...
Will Mounjaro Disrupt Existing Therapy Areas Like Cardiology?
Something remarkable has happened in the Indian pharmaceutical market....
Can India Pivot From Low-Cost Medical Tourism to Trusted Medical Value Travel?
C-Suite Executive Summary
India stands at a pivotal juncture in...
Rajesh Bhogavalli has been appointed as Chief Commercial Officer of ACG Group.
With over 25 years of leadership experience across commercial...
How To See Dr Reddy’s Nestle In The Wellness Shift
GLP-1 medicines such as semaglutide and tirzepatide are changing...
How To Power The India Biopharma Regulatory Revolution Now
Beyond the Pharmacy of the World: Why India's Biopharma...
Will Mounjaro Disrupt Existing Therapy Areas Like Cardiology?
Something remarkable has happened in the Indian pharmaceutical market....
Can India Pivot From Low-Cost Medical Tourism to Trusted Medical Value Travel?
C-Suite Executive Summary
India stands at a pivotal juncture in...
Rajesh Bhogavalli has been appointed as Chief Commercial Officer of ACG Group.
With over 25 years of leadership experience across commercial...
MedicinMan was launched in 2011 as India’s 1st Magazine dedicated to the cause of Field Force Excellence in Pharma and Devices.
Read More
Headlines
How To See Dr Reddy’s Nestle In The Wellness Shift
GLP-1 medicines such as semaglutide and tirzepatide are changing...
How To Power The India Biopharma Regulatory Revolution Now
Beyond the Pharmacy of the World: Why India's Biopharma...
Will Mounjaro Disrupt Existing Therapy Areas Like Cardiology?
Something remarkable has happened in the Indian pharmaceutical market....
Can India Pivot From Low-Cost Medical Tourism to Trusted Medical Value Travel?
C-Suite Executive Summary
India stands at a pivotal juncture in...
Newsletter
Get important news delivered directly to your inbox and stay connected!